Abstract
A patient with slight dilatation of the main pancreatic duct was followed-up with ultrasonography every 6 months as a high-risk case of pancreatic cancer. Twelve years later, a faint hypoechoic area 13 mm in diameter was first detected on the body of the pancreas. Contrast-enhanced ultrasonography revealed a well-demarcated hypoenhanced area 8 mm in diameter and a hyperenhanced area with an unclear margin. The former was suspected to be a small pancreatic cancer lesion, and the latter to be focal pancreatitis accompanying cancer. However, contrast-enhanced dynamic CT did not suggest any tumor, diagnosis of adenocarcinoma was confirmed with pancreatic juice cytology through endoscopic retrograde pancreatography. Surgical resection was performed, and the lesion was pathologically diagnosed as invasive ductal carcinoma as follows: pTS1 (1.0 cm), infiltrative type (pT1), stage IA. When comparing the images from contrast-enhanced ultrasonography with the pathological findings, the hypoenhanced area corresponded to ductal adenocarcinoma, and the hyperenhanced area to focal pancreatitis. Contrast-enhanced ultrasonography was able to reveal detailed information on the focal lesion in the pancreas, and it was effective for the early diagnosis of pancreatic cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Japan pancreas society. General rules for the study of pancreatic cancer. 7th ed. Tokyo: Kanehara; 2016.
Tanaka S, Nakaizumi A, Ioka T, et al. Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer. Jpn J Clin Oncol. 2002;32:407–11.
Tanaka S, Nakao M, Ioka T, et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as the predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254:965–72.
Tanaka S, Nakaizumi A, Ioka T, et al. Periodic ultrasonography checkup for the early detection of pancreatic cancer. Pancreas. 2004;28:268–72.
Nakao M, Katayama K, Fukuda J, et al. Evaluating the ability to detect pancreatic lesions using a special ultrasonography examination focusing on the pancreas. Eur J Radiol. 2017;91:10–4.
Foundation for Promotion of Cancer Research. Cancer statistics in Japan-2015. 2016. https://ganjoho.jp/reg_stat/index.html. Accessed 18 Jan 2017.
Guidelines for ultrasonic diagnosis of pancreatic cancer. Jpn Soc Ultrason Med. 2013;40:511–8.
Tanaka S, Kitamra T, Yamamoto K, et al. Evaluation of routine sonography for early detection of pancreatic cancer. JJCO. 1996;26:422–7.
Yoon SH, Lee JM, Cho JY, et al. Small (< 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259:442–52.
Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology. 2000;215:153–61.
Tanaka S, Ioka T, Oshikawa O, et al. Dynamic sonography of hepatic tumors. AJR. 2001;177:799–805.
Tanaka S, Hamada Y, Ioka T, et al. Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors. J Med Ultrason. 2005;32:57–63.
Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR. 2002;178:1133–7.
Ozawa Y, Numata K, Tanaka K, et al. Contrast-enhanced sonography of small pancreatic mass lesions. J Ultrasound Med. 2002;21:983–91.
Takeda K, Goto H, Hirooka Y, et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol. 2003;44:103–6.
Nagase M, Furuse J, Ishii H, et al. Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonography with a microbubble contrast agent. J Ultrasound Med. 2003;27:789–95.
Kitano M, Kudo M, Maekawa K, et al. Dynamic imaging of pancreatic disease by contrast enhanced coded phase inversion harmonic ultrasonography. GUT. 2004;53:854–9.
Takesima K, Kumada T, Toyoda H, et al. Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer. AJR. 2005;185:1193–200.
Ichino N, Horiguchi Y, Imai H, et al. Contrast-enhanced sonography of pancreatic ductal carcinoma using agent detection imaging. J Med Ultrason. 2006;33:29–35.
Oshima T, Yamaguchi T, Ishihara T, et al. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wideband Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas. 2004;28:335–43.
Numata K, Ozawa Y, Kobayashi N, et al. Contrast- enhanced sonography of pancreatic carcinoma: correlation with pathological findings. J Gastroenterol. 2005;40:631–40.
Faccioli N, D’Onofrio M, Malago R, et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margines at contrast-enhanced ultrasonography. Pancreas. 2008;37:265–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
All procedures performed in this study were in accordance with the ethical standard of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Informed consent
Written informed consent was obtained from the patient for being included in this study.
Conflict of interest
Fukuda J, Tanaka S, Ishida N, Ioka T, Ikezawa K, Takakura R, Nakao M, Ohkawa K, Katayama K, and Nagata S declare that they have no conflicts of interest.
About this article
Cite this article
Fukuda, J., Tanaka, S., Ishida, N. et al. A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography. J Med Ultrasonics 45, 617–622 (2018). https://doi.org/10.1007/s10396-018-0870-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-018-0870-5